FDSMEFBO: Family Model Diabetes Self-Management Education in Faith Based Organizations

Sponsor
University of Arkansas (Other)
Overall Status
Recruiting
CT.gov ID
NCT04256486
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD) (NIH)
576
1
2
37.4
15.4

Study Details

Study Description

Brief Summary

This study's objective is to conduct a cluster randomized control study that evaluates the effectiveness of F-DSME (Family Model Diabetes Self-Management Education) when delivered in a group setting in Marshallese Faith Based Organizations (FBO). The F-DSME has shown to be effective when delivered in patients' homes, and the proposed research will allow us to determine the F-DSME's effectiveness in a FBO setting.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Family Model Diabetes Self-Management Education and Support
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
576 participants
Allocation:
Randomized
Intervention Model:
Sequential Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Family Model Diabetes Self-Management Education in Faith Based Organizations
Actual Study Start Date :
Apr 21, 2022
Anticipated Primary Completion Date :
Jun 1, 2025
Anticipated Study Completion Date :
Jun 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Family DSMES

Behavioral: Family Model Diabetes Self-Management Education and Support
Participants assigned to this arm received an intervention that includes culturally-adapted DSME with their participating family members in a faith based organization setting.

Experimental: Wait List

Behavioral: Family Model Diabetes Self-Management Education and Support
Participants assigned to this arm received an intervention that includes culturally-adapted DSME with their participating family members in a faith based organization setting.

Outcome Measures

Primary Outcome Measures

  1. Glycemic Control, Measured by Change in Adjusted Mean HbA1c(%) From Baseline at various time points [Baseline, Immediate Post-intervention, 6 Months Post-intervention, 12 Months Post-intervention, 18 Months Post-intervention, 24 Months Post-intervention]

    Measured by Change in Adjusted Mean HbA1c(%) From Baseline to Immediate Post-intervention, 6 Months Post-intervention, 12 Months Post-intervention, 18 Months Post-intervention, and 24 Months Post-intervention.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • self-reported Marshallese

  • 18 years of age or older

  • have T2D (defined as having an HbA1c equal to or greater than 6.5)

  • have at least one family member willing to take part

Exclusion Criteria:
  • has received DSME in the past five years

  • has a condition that makes it unlikely that the participant will be able to follow the protocol, such as terminal illness, non-ambulatory, severe mental illness, severely impaired vision or hearing, eating disorder

  • plans to move out of the geographic region

Contacts and Locations

Locations

Site City State Country Postal Code
1 UAMS Northwest Springdale Arkansas United States 72762

Sponsors and Collaborators

  • University of Arkansas
  • National Institute on Minority Health and Health Disparities (NIMHD)

Investigators

  • Principal Investigator: Pearl McElfish, Phd, MDA, University of Arkansas

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Arkansas
ClinicalTrials.gov Identifier:
NCT04256486
Other Study ID Numbers:
  • 229034
  • 1R01MD013852-01
First Posted:
Feb 5, 2020
Last Update Posted:
Apr 26, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Arkansas
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 26, 2022